Few Children With SARS-CoV-2 Develop Post-COVID-19 Condition

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Dec. 28, 2023 -- Few children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop post-COVID-19 condition (PCC), according to a study published online Dec. 28 in JAMA Network Open.

Frederick Dun-Dery, Ph.D., M.Phil., from the University of Calgary in Alberta, Canada, and colleagues quantified the prevalence of PCC among children tested for SARS-CoV-2 infection in pediatric emergency departments in a multicenter prospective cohort study. Data were included for 5,147 children at six months (1,152 with SARS-CoV-2 positive tests and 3,995 with negative tests) and 5,563 children at 12 months (1,192 and 4,371 with positive and negative tests, respectively).

The researchers found that at six-month follow-up, symptoms and quality-of-life changes consistent with the PCC definition were present in 0.52 and 0.10 percent of children with positive and negative SARS-CoV-2 tests, respectively. At 12 months, 0.67 and 0.16 percent of children with positive and negative SARS-CoV-2 tests, respectively, met the definition for PCC. There was no significant difference in the PedsQL Generic Core Scale scores observed at 12 months among those with positive and negative SARS-CoV-2 tests. Of the eight children with SARS-CoV-2 positive tests and PCC at 12-month follow-up, 88, 38, and 13 percent reported respiratory, systemic, and neurologic symptoms, respectively.

"Although few children had PCC at 12 months, the prevalence was greater among SARS-CoV-2 infected children compared with controls," the authors write. "The likelihood of having symptoms that reduce daily functioning was 0.5 percent greater among those who tested positive for SARS-CoV-2 infection compared with those who tested negative."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-29 04:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords